×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LYEL – lyell immunopharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LYEL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/13
11:32 am
lyel
Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround [Yahoo! Finance]
Low
Report
Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround [Yahoo! Finance]
12/9
09:00 pm
lyel
Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting
Low
Report
Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting
11/19
08:41 am
lyel
LB Pharmaceuticals Names Heather Turner as CEO to Lead its Development of Transformative Advances in Schizophrenia Treatment [Yahoo! Finance]
Medium
Report
LB Pharmaceuticals Names Heather Turner as CEO to Lead its Development of Transformative Advances in Schizophrenia Treatment [Yahoo! Finance]
11/14
01:37 pm
lyel
Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
Neutral
Report
Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
11/14
08:22 am
lyel
Avalyn Appoints Heather Turner, J.D., Biopharma Industry Veteran, as Chair of its Board of Directors [Yahoo! Finance]
Low
Report
Avalyn Appoints Heather Turner, J.D., Biopharma Industry Veteran, as Chair of its Board of Directors [Yahoo! Finance]
11/12
08:33 am
lyel
Lyell Immunopharma, Inc. (NASDAQ: LYEL) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock.
Low
Report
Lyell Immunopharma, Inc. (NASDAQ: LYEL) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock.
11/7
04:05 pm
lyel
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
Low
Report
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
11/5
09:30 am
lyel
Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting
Medium
Report
Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/10
06:01 am
lyel
Form 8-K Lyell Immunopharma, Inc. For: Dec 09
Low
Report
Form 8-K Lyell Immunopharma, Inc. For: Dec 09
12/9
08:40 am
lyel
Form 424B5 Lyell Immunopharma, Inc.
Neutral
Report
Form 424B5 Lyell Immunopharma, Inc.
12/6
06:02 am
lyel
Form EFFECT Lyell Immunopharma, Inc.
Low
Report
Form EFFECT Lyell Immunopharma, Inc.
11/29
04:20 pm
lyel
Form S-3 Lyell Immunopharma, Inc.
Medium
Report
Form S-3 Lyell Immunopharma, Inc.
11/26
04:06 pm
lyel
Form 8-K Lyell Immunopharma, Inc. For: Nov 22
Low
Report
Form 8-K Lyell Immunopharma, Inc. For: Nov 22
11/12
04:05 pm
lyel
Form SC 13G/A Lyell Immunopharma, Inc. Filed by: VANGUARD GROUP INC
Medium
Report
Form SC 13G/A Lyell Immunopharma, Inc. Filed by: VANGUARD GROUP INC
11/7
04:21 pm
lyel
Form 10-Q Lyell Immunopharma, Inc. For: Sep 30
Neutral
Report
Form 10-Q Lyell Immunopharma, Inc. For: Sep 30
11/7
04:11 pm
lyel
Form 8-K Lyell Immunopharma, Inc. For: Nov 07
Neutral
Report
Form 8-K Lyell Immunopharma, Inc. For: Nov 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: